Jacobson Pharma Announces FY2022 Interim Results
- Written by Media Outreach
Robust Growth of 11.6% in Generics Business Amidst the Pandemic; Confident about Sustaining Strong Growth Momentum
Declares Interim Dividend of HK1.2 Cents Per Share; A 50% Growth Compared to FY2021 Interim
HONG KONG SAR - Media OutReach - 26 November 2021 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the...














